Ying Song

Organ Recovery Systems, Inc.

$1,317,732

Attributed

$1,317,732

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $410.9K · FY2005–08

$500K$375K$250K$125K$0

'05

'06

'07

'08

Funding mix

By agency

NIH$1,317,732 · 5

By mechanism

R44$801,359 · 1

R43$324,449 · 3

R03$191,924 · 1

Top collaborators

No co-investigators on record.

Most similar at Organ Recovery Systems, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Cryopreservation”

David R. Weir · University Of Michigan At Ann Arbor$155,816,163
Joseph B. Margolick · Johns Hopkins University$72,824,576
Kc Kent Lloyd · University Of California At Davis$65,512,040
Stephen Lev Hoffman · Sanaria, Inc.$61,516,697
Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$40,452,161
Deborah Phippard · Precision Bioservices, Inc.$38,445,894

Research focus

CryopreservationTechnology /Technique DevelopmentTissue EngineeringPancreasCryoprotective AgentsFreezingTissue /Organ Preservation3-DimensionalAmericanCollagenBeta CellBiomechanicsBiopsyAdultAllogenicAutologousCellular EngineeringCarotid ArteryCell LineCell ModelBaseCell PhysiologyCellsApoptosis

Grant awards (7)

VITRIFICATION OF RECOMBINANT NON-BETA CELLS IN CONSTRUCTS$94,993

R03 · FY2008 · EB · contact PI

VITRIFICATION OF RECOMBINANT NON-BETA CELLS IN CONSTRUCTS$96,931

R03 · FY2007 · EB · contact PI

VITRIFICATION FOR TISSUE ENGINEERED BLOOD VESSELS$410,890

R44 · FY2005 · HL

VITRIFICATION FOR TISSUE ENGINEERED BLOOD VESSELS$390,469

R44 · FY2004 · HL

ICE-FREE PRESERVATION OF OVARIES FOR LONG-TERM FECUNDITY$119,076

R43 · FY2004 · HD

VITRIFICATION FOR TISSUE ENGINEERED PANCREAS$105,373

R43 · FY2002 · DK

VITRIFICATION FOR TISSUE ENGINEERED BLOOD VESSELS$100,000

R43 · FY2001 · HL